Korean Lepr Bull. 2020 Dec;53(1):23-34. Korean.
Published online Dec 29, 2020.
Copyright © 2020 Society of Korean Leprologists
Original Article

The Study of Association between Leprosy's Type and Apolipoprotein E Gene in Korean Persons Affected by Leprosy

Jin-Ho Park, Yun-Ji Kim and Jong-Pill Kim
    • Institute for Leprosy Research, Korean Hansen Welfare Association, Korea.

Abstract

Background

Apolipoprotein E protein is a family of apolipoproteins that play an important role in lipid metabolism. Apolipoprotein E genotype and single-nucleotide polymorphisms of genes are known to induce neurodegenerative diseases and cardiovascular diseases. Recently, it has been reported that apolipoprotein E is related to Hansen's disease by regulating genes related to lipid metabolism.

Objective

In this study, we investigated that relationship of apolipoprotein E genotype with leprosy type and single-nucleotide polymorphism in korean persons affected by leprosy.

Methods

The Apolipoprotein E genotype was confirmed using the polymerase chain reaction from korean persons affected by leprosy. Real-time polymerase chain reaction using probes confirmed the rs405509 and rs439401 of Apolipoprotein E. The identified genotype was cross-analyzed with each single-nucleotide polymorphism results and leprosy type by chi-squared test.

Results

The distribution of apolipoprotein E genotypes was E3/E3 76.7%, E3/E4 17.4%, E2/E2 2.3%, E2/E3 2.3%, E2/E4 1.2% were in order. The frequencies of the apolipoprotein E allele were identified in the order of ε2 4.1%, ε3 86.6%, and ε4 9.3%. By type of leprosy, ε2 allele increased 2.2 times in multibacillary than pauacibacillary(4.8% vs 2.2%), and ε4 allele decreased 2.8 times in multibacillary than pauacibacillary(6.3% vs 17.4%). ApoE genotype was cross-analyzed with rs405509·rs439401, and there was a statistically significant association.

Conclusion

Apolipoprotein E genotype is associated with leprosy types in korean persons affected by leprosy. The research for apolipoprotein E gene is thought to be helpful in basic research on the pathogenesis of leprosy.who underwent surgery.

Keywords
Apolipoproteins E; Leprosy; Mycobacterium leprae; Single-nucleotide polymorphism

Tables

Table 1
Distribution of ApoE genotypes

Table 2
Relationship between ApoE genotypes and leprosy types

Table 3
Comparison of ApoE gene allele by leprosy types

Table 4
Relationship between each ApoE allele group and leprosy types

Table 5
Relationship between ApoE single-nucleotide polymorphisms (SNPs) and leprosy types

Table 6
Relationship between ApoE single-nucleotide polymorphisms (SNPs) and genotypes

Table 7
Relationship between each ApoE allele group and leprosy types

References

    1. McMurray DN. Mycobacteria and nocardia. In: Medical Microbiology. 4th ed. University of Texas Medical Branch at Galveston; 1996.
    1. WHO SEARO/Department of Control of Neglected Tropical Diseases. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. 2018. pp. 2.
    1. Jung EK. In: Guidelines for Hansen's disease program. 1st ed. Korea Centers for Disease Control and Prevention; 2019.
    1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1998;240:622–630.
    1. Puglielli L, Tanzi RE. Alzheimer's disease: the cholesterol connection. Nat Neurosci 2003;6:345–351.
    1. Egert S, Rimbach G, Huebbe P. ApoE genotype: from geographic distribution to function and responsiveness to dietary factors. Proc Nutr Soc 2012;71:410–424.
    1. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433–440.
    1. Sparks DL. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease. Ann N Y Acad Sci 1997;826:128–146.
    1. Choi CK, Kweon SS, Lee YH, Nam HS, Park KS, Ryu SY, et al. The Association between the Apolipoprotein E Gene Polymorphism and All-cause Mortality in the Korean Population. J Korean Med Sci 2019;34:e269
    1. Liu CC, Kanekiyo T. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 2013;9:106–118.
    1. Jung AN, Lee YJ, Choi SK, Park JO, Woo MS, Yu KN. A Study on the Statistical Evaluation of Apolipoprotein E Genotype and Alzheimers Disease. J Kor Phys Ther 2014;36:110–114.
    1. Wang D, Zhang DF, Li GD, Bi R, Fan Y, Wu Y, et al. A pleiotropic effect of the APOE gene: association of APOE polymorphisms with multibacillary leprosy in Han Chinese from Southwest China. Br J Dermatol 2018;178:931–939.
    1. MORGADO DE ABREU MAM. Association of APOE polymorphisms with multibacillary leprosy. Br J Dermatol 2018;178:833–834.
    1. Kikuchi M, Hara N, Hasegawa M, Miyashita A, Kuwano R, Ikeuchi T, et al. Enhancer variants associated with Alzheimer’s disease affect gene expression via chromatin looping. BMC Med Genomics 2019;12:128
    1. Huang M, Wang Y, Wang L, Chen B, Wang X, Hu Y. APOE rs405509 polymorphism and Parkinson’s disease risk in the Chinese population. Neurosci Lett 2020;736:135256
    1. Mattos KA, D'Avila H, Rodrigues LS, Oliveira VG, Sarno EN, Atella GC, et al. Lipid droplet formation in leprosy: TollXMLLink_XYZlike receptorXMLLink_XYZregulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J Leukoc Biol 2010;87:371–384.
    1. Underhill DM. Mini-review Toll-like receptors: networking for success. Eur J Immunol 2003;33:1767–1775.
    1. Elamin AA, Stehr M, Singh M. Lipid droplets and Mycobacterium leprae infection. J Pathog 2012;2012:10.
    1. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA 1994;272:1666–1671.
    1. Breslow JL, Zannis VI, SanGiacomo TR, Third JL, Tracy T, Glueck C. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res 1984;23:1224–1235.
    1. Feussner G, Feussner V, Hoffmann M, Lohrmann J, Wieland H, Marz W. Molecular basis of type III hyperlipoproteinemia in Germany. Hum Mutat 1998;11:417–423.
    1. Civeira F, Pocov M, Cenarro A, Casao E, Vilella E, Joven J, et al. Apo E variants in patients with type III hyperlipoproteinemia. Atherosclerosis 1996;127:273–282.
    1. Choi YH, Lee WR. ACE and ApoE Genotypes and their influences on plasma lipids in Korean men. J Korean Geriatr Soc 1998;2:18–26.
    1. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349–1356.
    1. NaserpourFarivar T, Sharifi Moud B, Sargazi M, Moeenrezakhanlou A. Apolipoprotein E polymorphism in tuberculosis patients. J Appl Sci 2008;8:719–722.
    1. Choi KY, Lee JJ, Gunasekaran TI, Kang S, Lee W, Jeong J. APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer's Disease Risk in a Multiracial Sample. J Clin Med 2019;8:1236

Metrics
Share
Tables

1 / 7

PERMALINK